The US plan to regulate over-the-counter derivatives could severely undermine the inter-dealer brokers that have fought hard to keep the market private.

Leading inter-dealer brokers, such as Icap and Tullett Prebon, would lose a vast chunk of business if they were forced to move all standardised OTC derivatives onto exchanges.